1. Home/
  2. Compounds/
  3. ABT-263

ABT-263

Synonyms

SourcesNames Used
GDSC1000, FIMMNavitoclax
CTRPv2navitoclax
PharmacoGx ABT-263

External IDs

DatabaseIdentifier
Smiles: CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C
Inchikey: JLYAXFNOILIKPP-KXQOOQHDSA-N
Pubchem: 24978538

Annotated Targets

BCL2, BCL2L2, BAD

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to ABT-263


Feature TypeStandardized
Nominal ANOVA
mRNA ZSCAN12 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA ZSCAN18 CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA ZSCAN2 CTRPv2 pan-cancer AAC 0.24 4e-10
mRNA ZSCAN23 CTRPv2 pan-cancer AAC 0.19 3e-06
mRNA ZSCAN25 CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA ZSCAN30 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA ZSCAN5A CTRPv2 pan-cancer AAC 0.14 7e-05
mRNA ZSWIM4 CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA ZSWIM5 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA ZZEF1 CTRPv2 pan-cancer AAC 0.14 0.0001
Download CSV